Skip to main content

Myelodysplastic Syndromes (MDS)

  • Living reference work entry
  • First Online:
Encyclopedia of Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 153 Accesses

Synonyms

Dysmyelopoietic syndromes; Oligoblastic leukemia; Preleukemic syndromes

Definition

Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal bone marrow disorders characterized by ineffective hematopoiesis due to functional abnormalities of maturing hematopoietic stem cell (HSC). Abnormal HSC actively proliferates, but is unable to undergo the normal differentiation necessary to produce mature circulating elements of the three hematopoietic lineages (i.e., erythroid, granulocytic, and megakaryocytic) and dies in the bone marrow through programmed cell death or apoptosis. This ineffective hematopoiesis manifests clinically with peripheral blood (PB) cytopenia(s) and morphologically with single lineage or multilineage dysplasia.

With disease progression, HSC in MDS acquires multistep alterations, the accumulation of which may eventually cause transformation to acute myeloid leukemia (AML).

Clinical Features

Incidence and Age

The annual incidence of MDS in the general...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References and Further Reading

  • Greenberg, P. L., Tuechler, H., Schanz, J., et al. (2012). Revised international prognostic scoring system for myelodysplastic syndromes. Blood, 120(12), 2454–2465.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hasserjian, R. P., Orazi, A., Brunning, R. D., et al. (2017). Myelodysplastic syndromes Chapter 6. In S. H. Swerdlow et al. (Eds.), WHO classification of tumours of haematopoietic and lymphoid tissues (Revised 4th ed., pp. 97–120). Lyon: IARC.

    Google Scholar 

  • Malcovati, L., Germing, U., Kuendgen, A., et al. (2007). Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. Journal of Clinical Oncology, 25(23), 3503–3510.

    Article  PubMed  Google Scholar 

  • Malcovati, L., Gallì, A., Travaglino, E., et al. (2017). Clinical significance of somatic mutation in unexplained blood cytopenia. Blood, 129(25), 3371–3378.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Margolskee, E., Hasserjian, R. P., Hassane, D., et al. (2017). Myelodysplastic syndrome, unclassifiable (MDS-U) with 1% blasts is a distinct dubgroup of MDS-U with a poor prognosis. American Journal of Clinical Pathology, 148(1), 49–57.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valentina F. I. Sangiorgio .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Sangiorgio, V.F.I., Orazi, A. (2018). Myelodysplastic Syndromes (MDS). In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_4695-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_4695-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics